AbbVie
AbbVie is a research-based biopharmaceutical company that discovers, develops, manufactures, and markets advanced therapies in immunology, oncology, neuroscience, and other specialty areas. AbbVie's portfolio includes treatments for autoimmune diseases, various cancers, neurological disorders, and aesthetics through the Allergan Aesthetics portfolio.
Features
Treatments for rheumatoid arthritis, psoriasis, IBD, and other immune-mediated diseases including Humira and Skyrizi
Hematologic malignancy treatments and solid tumor therapies including Imbruvica and Venclexta
Treatments for Parkinson's disease, migraine, and psychiatric conditions
Medical aesthetics products through the Allergan Aesthetics portfolio
Research-based drug discovery leveraging genomics, proteomics, and AI/ML approaches
Use Cases
Access clinical trial results and outcomes data for research and regulatory submissions
Connect patient access programs and medication assistance with healthcare systems
Provide healthcare professionals with product information and medical affairs resources
Collect and analyze real-world patient data for post-market surveillance
Integrations
Integration with EHR systems for clinical data exchange and prescribing information
Integration with CTMS platforms for clinical trial data collection and management
Integration with pharmacy and insurance systems for patient access programs